By analyzing genes from both parents, the CellaGene B Test helps detect whether your baby may be at risk for conditions such as cystic fibrosis, beta-thalassemia, and sickle cell disease. Detecting potential inherited genetic diseases during pregnancy is a proactive step to protect your child’s health and prepare for the right medical care.
The CellaGene B Test is a safe blood test that identifies whether your baby may be at risk for inherited genetic diseases such as cystic fibrosis, beta-thalassemia, and sickle cell disease. By analyzing genes from both parents, the test provides valuable knowledge during pregnancy so you can prepare for your child’s future health needs. Many severe hereditary diseases are recessive, which means parents can be healthy carriers without knowing it. If both parents carry the same gene mutation, the child may inherit two abnormal genes and develop the disease. The test is especially important for families with a history of cystic fibrosis, beta-thalassemia, or sickle cell disease, but it can provide valuable information for all expectant parents. Early knowledge allows families to prepare for possible healthcare needs and secure the best support for their child. The test is a non-invasive blood-based analysis with a high level of accuracy. The CellaGene B Test is designed to identify some of the most significant inherited genetic diseases. These conditions often remain hidden because parents can be healthy carriers without showing symptoms. By detecting risks early, families gain valuable knowledge that supports faster diagnosis, early intervention, and better long-term care for their child. The most common inherited diseases worldwide! About 7% of the world’s population carries changes in the hemoglobin gene. Haemoglobinopathies, such as beta-thalassemia and sickle cell disease, are blood disorders that can cause chronic anemia, organ damage, and increased risk of infection. Early detection through genetic testing can help prevent severe complications such as stroke, acute chest syndrome, and bone damage. Prevalent in Mediterranean regions! This condition is especially common in Mediterranean countries such as Spain, Italy, Greece, and Turkey, as well as in North Africa, India, and the Middle East. Most common in tropical regions! Sickle cell disease is primarily found in sub-Saharan Africa, India, and the Middle East. It can cause painful crises, anemia, and organ complications if left unmanaged. The most common life-limiting hereditary disease among people of European heritage! Cystic fibrosis affects the lungs, digestive system, and other organs. Around 1 in 25 people of European descent and 1 in 30 white Americans carry a CF mutation. Even in populations where the disease is less common, between 1 in 30 and 1 in 90 people may be carriers. Symptoms include chronic lung infections, poor nutrient absorption, liver disease, sinus problems, and reproductive issues. Early detection allows for faster treatment and improved long-term outcomes. The CellaGene B Test is simple and safe. The CellaGene B Test requires 20 ml of blood from the mother and 10 ml from the father. All samples are collected by Cellaviva’s staff using special blood tubes provided by us. The test is currently available in and around Stockholm, Gothenburg, Västerås, and Skåne. The samples are sent to the laboratory, and results are usually ready within 1 month. Price: SEK 9,800 Timeframe for results: about 1 month from arrival at the laboratory
Prenatal testing:
CellaGene B Test
Think ahead. Act now!
A safe and reliable way to identify the risk of inherited genetic diseases in your child
Why take the CellaGene B Test?
Which diseases does the CellaGene B Test focus on?
About the process:
Order your CellaGene B Test kit today